Cleared Traditional

K181225 - ALTAPORE

K181225 is an FDA 510(k) clearance for ALTAPORE, manufactured by Baxter Healthcare Corporation. The device is a Class 2 Orthopedic device with product code MQV cleared through the Traditional 510(k) pathway after a 115-day FDA review.

K181225 · Baxter Healthcare Corporation · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2018
Decision
115d
Days
Class 2
Risk

K181225 is an FDA 510(k) clearance for the ALTAPORE. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Baxter Healthcare Corporation (Round Lake, US). The FDA issued a Cleared decision on August 31, 2018 after a review of 115 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Baxter Healthcare Corporation devices

FDA 510(k) Submission Details - K181225

510(k) Number K181225 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 08, 2018
Decision Date August 31, 2018
Days to Decision 115 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
7d faster than avg
Panel avg: 122d · This submission: 115d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQV Device Classification - Class 2, Special Controls

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 407
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K181225.
Sorrento Bioglass Bone Graft Substitute
K173933 · Xenco Medical, LLC · Sep 2018
BioSphere Flex
K173424 · Synergy Biomedical · Sep 2018
PRODENSE Bone Graft Substitute
K181255 · Wrightmedicaltechnologyinc · Sep 2018
CarriGen PF
K182107 · Etex Corporation · Aug 2018
Actifuse Flow
K181306 · Baxter Healthcare Corporation · Aug 2018
EP Granules™ BVF
K180853 · Elute, Inc. · Aug 2018